Thermo Fisher Scientific Inc. (LON:0R0H)
406.47
-4.38 (-1.07%)
At close: May 9, 2025
Thermo Fisher Scientific Revenue
Thermo Fisher Scientific had revenue of $10.36B USD in the quarter ending March 29, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to $42.90B, up 0.96% year-over-year. In the year 2024, Thermo Fisher Scientific had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$42.90B
Revenue Growth
+0.96%
P/S Ratio
3.73
Revenue / Employee
$343.18K
Employees
125,000
Market Cap
123.61B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Thermo Fisher Scientific News
- 6 days ago - 10 Undervalued Dividend Growth Stocks: May 2025 - Seeking Alpha
- 7 days ago - Thermo Fisher Scientific to Present at BofA Securities 2025 Health Care Conference on May 13 - Business Wire
- 13 days ago - 3 Of The Cheapest High-Quality Stocks Money Can Buy - Seeking Alpha
- 13 days ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 14 days ago - Is Thermo Fisher Scientific Gaining or Losing Market Support? - Benzinga
- 15 days ago - Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics - Business Wire
- 18 days ago - Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan - Benzinga
- 18 days ago - Thermo Fisher Doubles Down On US Manufacturing In $2B Expansion Plan - Benzinga